Combination PET/CT should be used to determine stage of non-small cell lung cancer

The combination of real-time PET and CT is a highly sensitive tool for identifying non-small cell lung cancer (NSCLC) and can assist in identifying patients whose cancer has not yet spread to lymph nodes, according to results of a study by researchers at Johns Hopkins.

The findings are important because they suggest that combination PET/CT should be included during the early part of diagnosis, when physicians are trying to determine the stage of the cancer. The seriousness of NSCLC is rated from N0 to N3, with N0 being cancer that has not spread from the original tumor; and N1 to N3 referring to increasingly serious stages that have spread to lymph nodes.

However, the study also found that the combination of PET and CT is less sensitive in identifying benign nodules, that is, non-cancerous lumps of tissue. Moreover, the overall process of determining the stage of NSCLC remains difficult, especially in differentiating between N1 and N2 stages of cancer, the Hopkins researchers note.

"PET is already widely used to evaluate cancer nodules and determine their stage," says Stephen C. Yang, M.D., associate professor of surgery and oncology and chief of the Division of Thoracic Surgery at Johns Hopkins. "Our study will help show whether a combination of PET and CT can accurately determine the cancer stage in patients who might be effectively treated surgically rather than require chemotherapy, especially in the N0 stage." Yang presented these results this week at the 84th annual meeting of the American Association of Thoracic Surgeons in Toronto.

In the Hopkins study, PET/CT correctly identified 94 of 100 (94 percent) malignant lesions (tumors) in patients, but only eight of 22 (36 percent) of lumps that were not cancerous. The technique correctly identified the stage of cancer in 61 of 100 patients (i.e., 56 with stage N0, two with N1 and three with N3).

However, combination PET/CT overstaged the tumor (identified cancer as b

Contact: Trent Stockton
Johns Hopkins Medical Institutions

Page: 1 2

Related medicine news :

1. Combination treatment helps thyroid cancer patients live longer
2. Combination therapy, not medication alone, most effective for treating children with OCD
3. Combination of erection pill and testosterone gel may benefit men who fail treatment with pill alone
4. Combination therapy w/ ACTOS (pioglitazone HCI) shown to improve components of diabetic dyslipidemia
5. Combination of toxin and poison may be novel treatment for leukemia
6. Combination drug therapy could substantially improve symptoms of rheumatoid arthritis
7. Combination therapy does not appear to benefit cardiac patients before heart catheter procedure
8. Combination drug therapy offers hope for malaria treatment
9. Combination therapy significantly delays progression of benign prostatic hyperplasia
10. Combination, order of anti-HIV drugs make a difference in first-time recipients
11. Combination of HIV/malaria increases complications during pregnancy

Post Your Comments:

(Date:1/10/2020)... VANCOUVER, Wash. (PRWEB) , ... January 10, 2020 , ... ... today announced their partnership in a new online community coming in February 2020, LEAD ... in the Health and Wellbeing Village. , The vision of LEAD WELL with WOMEN ...
(Date:1/10/2020)... ... 2020 , ... SMG3Rx, a clinical mobility platform powered by ... (Healthcare Information and Management Systems Society) Global Conference & Exhibition taking place on ... event of the year, where professionals throughout the global health ecosystem connect for ...
(Date:1/8/2020)... ... 2020 , ... Pyxa Solutions, a leading provider of consulting, ... is rebranding as Red Nucleus R&D, a division of Red Nucleus. Red Nucleus ... industry. , The addition of Red Nucleus R&D under the Red Nucleus ...
(Date:1/8/2020)... ... January 09, 2020 , ... Real ... Webinar, Thursday, Jan. 23, 2020 • 1:30-3:00 p.m. EST, https://www.centerwatch.com/rweanddata ... (RWD) to generate evidence and identify gaps and challenges when conducting trials? The ...
(Date:1/7/2020)... Texas (PRWEB) , ... January 07, 2020 , ... ... today unveiled another facility expansion, adding to the company’s 200,000 sq. ft. manufacturing ... 25,000 sq. ft. of manufacturing space dedicated to POD architectural, mechanical, electrical and ...
Breaking Medicine News(10 mins):
(Date:1/22/2020)... ... January 22, 2020 , ... Clairvoyant Networks, ... Care GPS remote monitoring and communications technology was selected for demonstration in the ... showcases the latest technology and services for consumers and businesses needing solutions that ...
(Date:1/12/2020)... ... January 10, 2020 , ... ... has been selected to present at next week’s Biotech Showcase. Cytonus is ... with its proprietary Cargocyte™ next generation Adoptive Cellular Therapy (ACT) technologies which ...
(Date:1/10/2020)... ... January 10, 2020 , ... Reach ... Counselor Association, will celebrate high school counselors and award the first annual Excellence ... National Championship weekend and Extra Yard for Teachers Summit celebration on Saturday, January ...
Breaking Medicine Technology:
Cached News: